Excella these are phase 1 trials. The only conclusions are safety and efficacy ie that they can be given safely so far this has been the case and I imagine will be the same for the head And neck trials the phase 2 trials are to work out the correct dosage and monitor results there is no reason that this drug will not be used in some capacity particularly since the side effects have been negligible to date and results encouraging for all the oncoviruses to date even if they have partial responses with the minimal toxicity these drugs will be used and that equals big bucks when phase two trials are concluded this little babe will be taken over by a large pharma company good luck to all long termers BD
VLA Price at posting:
5.7¢ Sentiment: LT Buy Disclosure: Held
